Stock screener

IMNN

Conviction 0HealthcareScan · Mon, Aug 10, 2026
IMNN$1.60-0.62%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 110.97K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Imunon, Inc.PHARMACEUTICAL PREPARATIONSwww.imunon.com
Price1.60
Change-0.62%
Gap+1.24%
Rel volume0.07×
Avg volume261.22K
Avg $ vol431.77K
SMA 201.66
SMA 501.83
SMA 2003.00
Price vs 50-12.77%
Price vs 200-46.59%
MA stackbearish
50/200 cross
Supertrenddown · 1.95
RSI (14)40
MACD hist0.01
MACD crossbull · 4d
Stoch %K / %D52 / 33
ADX (14)23
+DI / −DI21 / 11
RSI divergenceBullish
MACD divergence
ATR %+7.84%
ADR %7.36%
52w high7.18
52w low1.51
From 52w high-77.72%
Above 52w low+5.96%
New 52w highNo
SqueezeOff
Bollinger width32.78%
%B0.39
Donchian pos21.31%
Donchian high2.08
Donchian low1.47
AVWAP (52w high)3.29
vs AVWAP high-51.41%
AVWAP (52w low)1.61
vs AVWAP low-0.49%
OBV trendDown
Chaikin MF (20)-0.46
Today vs 20d0.07×
Avg vol (14d)110.97K
Avg vol (20d)261.22K
Avg $ vol (20d)431.77K
Market cap6.72M
RS 3m (vs SPY)-46.72%
RS 6m (vs SPY)-61.67%
RS line new highNo
Trend template0/8
Technical rank9.2
1 week+1.27%
1 month-20.79%
3 months-41.18%
6 months-51.07%
1 year-76.98%
YTD-59.49%
P/E-0.46
P/B2.00
P/S13.45
P/FCF-0.47
EPS-6.83
Div yield
ROE-431.45%
ROA-180.76%
Debt/Eq1.81
Current1.59
EV/EBITDA-0.58
Gross margin
Net margin
Rev growth0.00%
EPS growth22.15%
Price target
Target upside
Analyst rating
Institutional
Ent. value8.01M
Revenue125K
Net income-4.25M
Gross profit
Free cash flow-14.18M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out4.2M
Employees20
ListedMon, Jul 24, 1995
Free float2.33M
Float %59.3%
Short interest18.39K
Days to cover0.6d
Short volume57.4%
Squeeze score16 / 100
Next earningsTue, Aug 11, 2026 · pre-mkt (1d)
EPS forecast−$0.94 · 3 est
Last EPS vs est
Last surprise
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank9.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance2.17
Support1.51
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMNN

All disclosures →
No recent disclosed trades by Congress in IMNN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMNN · 8 buys · 2 sells

InsiderSideShares
Eylward Susan
General Counsel and Corp Sec · Common Stock · 2026-07-06
Sell920
Eylward Susan
General Counsel and Corp Sec · Common Stock · 2026-07-02
Grant920
Faller Douglas Vincent
Chief Medical Officer · Common Stock · 2026-07-02
Grant1.31K
Lindborg Stacy
President and CEO · Common Stock · 2026-07-02
Grant2.53K
Tardugno Michael H
Executive Chairman of Board · Common Stock · 2026-07-02
Grant4.41K
Eylward Susan
General Counsel and Corp Sec · Common Stock · 2026-06-29
Sell11.8K
Tardugno Michael H
Executive Chairman of Board · Common Stock · 2026-06-25
Grant42.52K
Faller Douglas Vincent
Chief Medical Officer · Common Stock · 2026-06-25
Grant21.9K
Eylward Susan
General Counsel and Corp Sec · Common Stock · 2026-06-25
Grant14.7K
Lindborg Stacy
President and CEO · Common Stock · 2026-06-25
Grant67.15K

SEC filings

EDGAR filings in IMNN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.